» Articles » PMID: 36090701

Epidemiological Characteristics and Transmission Dynamics of the Outbreak Caused by the SARS-CoV-2 Omicron Variant in Shanghai, China: A Descriptive Study

Abstract

Background: In early March 2022, a major outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant spread rapidly throughout Shanghai, China. Here we aimed to provide a description of the epidemiological characteristics and spatiotemporal transmission dynamics of the Omicron outbreak under the population-based screening and lockdown policies implemented in Shanghai.

Methods: We extracted individual information on SARS-CoV-2 infections reported between January 1 and May 31, 2022, and on the timeline of the adopted non-pharmaceutical interventions. The epidemic was divided into three phases: i) sporadic infections (January 1-February 28), ii) local transmission (March 1-March 31), and iii) city-wide lockdown (April 1 to May 31). We described the epidemic spread during these three phases and the subdistrict-level spatiotemporal distribution of the infections. To evaluate the impact on the transmission of SARS-CoV-2 of the adopted targeted interventions in Phase 2 and city-wide lockdown in Phase 3, we estimated the dynamics of the net reproduction number ( ).

Findings: A surge in imported infections in Phase 1 triggered cryptic local transmission of the Omicron variant in early March, resulting in the largest outbreak in mainland China since the original wave. A total of 626,000 SARS-CoV-2 infections were reported in 99.5% (215/216) of the subdistricts of Shanghai until the end of May. The spatial distribution of the infections was highly heterogeneous, with 37% of the subdistricts accounting for 80% of all infections. A clear trend from the city center towards adjacent suburban and rural areas was observed, with a progressive slowdown of the epidemic spread (from 463 to 244 meters/day) prior to the citywide lockdown. During Phase 2, remained well above 1 despite the implementation of multiple targeted interventions. The citywide lockdown imposed on April 1 led to a marked decrease in transmission, bringing below the epidemic threshold in the entire city on April 14 and ultimately leading to containment of the outbreak.

Interpretation: Our results highlight the risk of widespread outbreaks in mainland China, particularly under the heightened pressure of imported infections. The targeted interventions adopted in March 2022 were not capable of halting transmission, and the implementation of a strict, prolonged city-wide lockdown was needed to successfully contain the outbreak, highlighting the challenges for containing Omicron outbreaks.

Funding: Key Program of the National Natural Science Foundation of China (82130093); Shanghai Rising-Star Program (22QA1402300).

Citing Articles

Contact patterns between index patients and their close contacts and assessing risk for COVID-19 transmission during different exposure time windows: a large retrospective observational study of 450 770 close contacts in Shanghai.

Zheng Y, Zheng B, Gong X, Pan H, Jiang C, Mao S BMJ Public Health. 2025; 2(1):e000154.

PMID: 40018114 PMC: 11812788. DOI: 10.1136/bmjph-2023-000154.


Predictors of stress among nucleic acid sampling support nurses (NASSNs) during the COVID-19 pandemic.

Feng P, Gu L, Lu X, Hu M, Weng Y, Chen W Hum Resour Health. 2025; 23(1):11.

PMID: 39962597 PMC: 11834485. DOI: 10.1186/s12960-025-00971-y.


Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai.

Zheng B, Goncalves B, Deng P, Wang W, Tian J, Liang X Elife. 2025; 13.

PMID: 39960759 PMC: 11832167. DOI: 10.7554/eLife.94990.


Infection with SARS-CoV-2 during the first trimester did not adversely impact perinatal and obstetric outcomes subsequent to in vitro fertilization with frozen embryo transfer: a retrospective cohort study.

Zhang J, Ye J, Gao H, Mao X, Wu L J Assist Reprod Genet. 2025; 42(2):589-598.

PMID: 39820830 PMC: 11871260. DOI: 10.1007/s10815-025-03390-z.


A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks.

Jeong Y, Ejima K, Kim K, Iwanami S, Hart W, Thompson R Commun Med (Lond). 2025; 5(1):2.

PMID: 39753869 PMC: 11699287. DOI: 10.1038/s43856-024-00716-3.


References
1.
McMenamin M, Nealon J, Lin Y, Wong J, Cheung J, Lau E . Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study. Lancet Infect Dis. 2022; 22(10):1435-1443. PMC: 9286709. DOI: 10.1016/S1473-3099(22)00345-0. View

2.
Backer J, Eggink D, Andeweg S, Veldhuijzen I, van Maarseveen N, Vermaas K . Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021. Euro Surveill. 2022; 27(6). PMC: 8832521. DOI: 10.2807/1560-7917.ES.2022.27.6.2200042. View

3.
Yamasoba D, Kimura I, Nasser H, Morioka Y, Nao N, Ito J . Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike. Cell. 2022; 185(12):2103-2115.e19. PMC: 9057982. DOI: 10.1016/j.cell.2022.04.035. View

4.
Li L, Han Z, Qin P, Liu W, Yang Z, Chen Z . Transmission and containment of the SARS-CoV-2 Delta variant of concern in Guangzhou, China: A population-based study. PLoS Negl Trop Dis. 2022; 16(1):e0010048. PMC: 8730460. DOI: 10.1371/journal.pntd.0010048. View

5.
Viana R, Moyo S, Amoako D, Tegally H, Scheepers C, Althaus C . Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022; 603(7902):679-686. PMC: 8942855. DOI: 10.1038/s41586-022-04411-y. View